It is the cause of 15% of premature births1 and of 42% of maternal decease during childbirth2.
Data required by the FMF algorithm:
Mean uterine artery pulsatility index (UTPI)
Biomarker PlGF from serum
Elecsys® sFlt-1/PlGF from Roche...
The use of the Elecsys® sFlt-1/PlGF ratio is a reliable tool to identify patients at high risk of developing pre-eclampsia who require closer monitoring.
Roche Diagnostics is committed to women’s health at every stage of her life and to giving healthcare providers the confidence to safeguard the moments that matter most. Our innovative solutions in women’s health give physicians the ability to provide the right treatment at the right time, offering a confidence that only Roche Diagnostics can deliver.
1. Tency l. et al. Perinatal referral in Belgium. FOD, 2007
2. Verlohren S. et al. (2010). Am J. Obstet Gynecol, 202 (161): e1-11
3. Milne et al. (2009) BMJ, 339:b3129
4. Health Belgium, 2019
5. O’Gorman et al. (2016). Am J. Obstet Gynecol, 214: 103.e1-12
6. O’Gorman N et al. (2017). Ultrasound Obstet Gynecol, 49: 756–760
7. Rolnik et al. (2017). N Engl J Med, 377(7):613-622
8. Poon L.C. et al, Int J Gynecol Obstet 2019;145(Suppl.1): 1-33
9. Zeisler H. et al. (2016). N Engl J Med, 374: 13-22
10. Verlohren et al. (2014). Hypertension, 63: 346-352
11. Lanssens, D. et al. (2017). JMIR mHealth and uHealth, 5(3), e25
12. KCE Report 232Cs. Caring for mothers and newborns after uncomplicated
delivery: towards integrated postnatal care
13. Statbel (2019, February 26). Feto-infant mortality
Retrieved March 12, 2019, from: https://statbel.fgov.be/en/themes/
population/feto-infant-mortality
14. Information received by request to FPS Health
15. Wright, D. et al. (2018). Am J Obstet Gynecol, 218(6), 612-e1
16. Terugbetalingsdossier Elecsys ® sFlt-1-PlGF immunoassay ratio. Submitted to RIZIV/INAMI November 2019
17. Hund, M., et al. (2014). BMC Pregnancy and Childbirth 14, 324
18. Zeisler, H., et al. (2016). N Engl J Med 374(1), 13-22
19. Hund, M., et al. (2015). Hypertens Pregnancy 34(1), 102-115
20. Klein, E., et al. (2014). PLoS ONE 11(5), e0156013
It is the cause of 15% of premature births1 and of 42% of maternal decease during childbirth2.
Risk assessment for pre-eclampsia in the 1st trimester helps to identify high-risk patients.
Roche Diagnostics is committed to women’s health at every stage of her life and to giving healthcare providers the confidence to safeguard the moments that matter most. Our innovative solutions in women’s health give physicians the ability to provide the right treatment at the right time, offering a confidence that only Roche Diagnostics can deliver.
1. Tency l. et al. Perinatal referral in Belgium. FOD, 2007
2. Verlohren S. et al. (2010). Am J. Obstet Gynecol, 202 (161): e1-11
3. Milne et al. (2009) BMJ, 339:b3129
4. Health Belgium, 2019
5. O’Gorman et al. (2016). Am J. Obstet Gynecol, 214: 103.e1-12
6. O’Gorman N et al. (2017). Ultrasound Obstet Gynecol, 49: 756–760
7. Rolnik et al. (2017). N Engl J Med, 377(7):613-622
8. Poon L.C. et al, Int J Gynecol Obstet 2019;145(Suppl.1): 1-33
9. Zeisler H. et al. (2016). N Engl J Med, 374: 13-22
10. Verlohren et al. (2014). Hypertension, 63: 346-352
11. Lanssens, D. et al. (2017). JMIR mHealth and uHealth, 5(3), e25
12. KCE Report 232Cs. Caring for mothers and newborns after uncomplicated
delivery: towards integrated postnatal care
13. Statbel (2019, February 26). Feto-infant mortality
Retrieved March 12, 2019, from: https://statbel.fgov.be/en/themes/
population/feto-infant-mortality
14. Information received by request to FPS Health
15. Wright, D. et al. (2018). Am J Obstet Gynecol, 218(6), 612-e1
16. Terugbetalingsdossier Elecsys ® sFlt-1-PlGF immunoassay ratio. Submitted to RIZIV/INAMI November 2019
